HIV 1 News and Research

RSS

RTS,S offers 46 percent protection against malaria for at least 15 months after vaccination, Study finds

A Phase II trial published Friday in Lancet Infectious Diseases has shown that RTS,S, the "experimental malaria vaccine from GlaxoSmithKline provides African children with long-lasting protection" against malaria, Reuters reports.

18 Jan 2011

Clinical studies by expert HIV clinicians suggest that HIV-TRePS may have clinical and economic benefits

Two multinational clinical studies indicate that the RDI’s system for predicting how HIV and AIDS patients will respond to different drugs could be a useful tool with potential clinical and economic benefits. The studies, published in the January issue of AIDS Patient Care and STDs, involved highly experienced physicians in the USA, Canada and Italy who used the system to help them select the optimum combination of HIV drugs for patients whose therapy was failing.

18 Jan 2011

Opinions: U.S. HIV funding; Global fund accountability; World food supply

President Barack Obama's Global Health Initiative is "pitting AIDS against other diseases by making investments in new areas of global health contingent on flat funding for efforts to fight the HIV epidemic," HIV/AIDS advocate and Yale College student Gregg Gonsalves writes in a Washington Post opinion piece.

18 Jan 2011

New evidence about broadly-reactive neutralizing antibodies that block HIV infection

New findings are bringing scientists closer to an effective HIV vaccine. Researchers from Seattle Biomedical Research Institute, Vanderbilt University and the Ragon Institute of MGH, MIT and Harvard report findings showing new evidence about broadly-reactive neutralizing antibodies, which block HIV infection. Details are published January 13 in the open-access journal PLoS Pathogens.

14 Jan 2011

Medical aid workers should take pre-travel precautions to prevent disease transmission

Guidance about pre-travel precautions and preventive measures are highlighted in the December 1, 2010 issue of Clinical Infectious Diseases, written by clinicians and researchers at the Uniformed Services University of the Health Sciences and their partners from the University of Texas Health Sciences Center, Naval Medical Research Center and others.

11 Jan 2011

Sangamo completes enrollment in SB-509-901 Phase 2b clinical trial in diabetic neuropathy

Sangamo BioSciences, Inc. announced today that the company completed enrollment of its Phase 2b double-blind, placebo-controlled clinical trial (SB-509-901) in subjects with diabetic neuropathy (DN). The company expects to have efficacy data from this study in the second half of 2011. The company also plans to present the first human clinical data from its Phase 1 trials of SB-728-T in HIV/AIDS in the first quarter of 2011.

10 Jan 2011

Positive preclinical results from Inovio's novel DNA vaccine targeting HIV Clade C virus

Inovio Pharmaceuticals, a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the publication of a scientific paper highlighting positive preclinical results from Inovio's novel DNA vaccine targeting HIV Clade C viruses in the journal Vaccine.

10 Jan 2011

Male circumcision helps reduce rates of HPV transmission to women, study finds

"Among HIV-negative sexual partners, male circumcision helps prevent the transmission of human papillomavirus [HPV] from men to women," according to a study published online Thursday in the Lancet, HealthDay News/Bloomberg Businessweek reports.

10 Jan 2011

New lab-on-a-chip technology detects protein in blood less than 30 minutes

While most blood tests require shipping a vial of blood to a laboratory for analysis and waiting several days for the results, a new device invented by a team of engineers and students at the University of Rhode Island uses just a pinprick of blood in a portable device that provides results in less than 30 minutes.

10 Jan 2011

IDSA releases MRSA treatment guidelines

Physicians now have help in their battle against methicillin resistant Staphylococcus aureus (MRSA), a potentially deadly infection that initially was limited to hospitals and health care facilities but has become a growing problem in healthy children and adults. The Infectious Diseases Society of America (IDSA) has released its first guidelines for the treatment of increasingly common MRSA infections.

7 Jan 2011

Opinions: Global health top foreign policy issue; Global food security; Opiate-substitution programs in Eastern Europe; Feed the future; Foreign aid lessons

In response to a story examining 2011's top foreign policy issues, Serra Sippel, president of the Center for Health and Gender Equity, writes in a letter to the editor, published in The Hill, that "[g]lobal health was disturbingly absent from" the story. "Global health policy is at a critical turning point right now with the impending implementation of President Obama's Global Health Initiative, which will change our fundamental approach to health programs and policy," according to Sippel.

7 Jan 2011

Profectus BioSciences commences GENEVAX IL-12 phase 1 study for HIV

Profectus BioSciences, a leader in the development of therapeutic and preventive vaccines against infectious diseases and cancers, and the AIDS Clinical Trials Group announced today the initiation of a phase 1 study of Profectus' multi-antigen HIV plasmid DNA vaccine administered with various doses of GENEVAX™ interleukin-12 pDNA adjuvant and delivered using the electroporation based TriGrid™delivery system developed by Ichor Medical Systems.

6 Jan 2011

Indian drugmaker seeks to make, sell generic version of Pfizer's HIV drug

The Indian drugmaker Natco Pharma "said Wednesday it has informed Pfizer Inc. that it wants to make and sell a low-cost generic version of the U.S. company's [drug] maraviroc for treating the HIV infection under a so-called 'compulsory license'," Dow Jones Newswires/Smart Money reports.

6 Jan 2011

OpEds: Sebelius, Fla. Attorney General, USA Today, Wash Post opine about repeal strategies

Over the past nine months, I've traveled around the country and seen the benefits of this law firsthand. Unless we want to take coverage away from cancer patients, reduce oversight for insurance companies, raise prescription drug costs for seniors, weaken Medicare, add $1 trillion to the deficit and undo dozens of other reforms that are improving health around the country, we can't afford repeal (Kathleen Sebelius, 1/5).

6 Jan 2011

UC professor receives Fulbright Scholar Award to explore health education efforts in China

The New Year has a University of Cincinnati professor sharing his vast and vital research background on health education in a new location. Randall Cottrell, a UC professor of health promotion and education in the College of Education, Criminal Justice, and Human Services (CECH), is spending the winter and spring academic quarters at Zhejiang University in Hangzhou, China.

5 Jan 2011

Indian government rejects Abbott's patent application for second-line ARV

India's patent office "has rejected American drug maker Abbott Laboratories' patent application for an HIV combination drug, allowing low-cost local drug makers to make and sell their generic versions in India and other countries where the medicine is not patented," Economic Times reports (1/4).

5 Jan 2011

Opinions: U.S. International Affairs Budget; Health impacts of climate change; Role of U.N.; Drug development, free trade

Despite challenging economic times, "[t]wo areas we cannot afford to shortchange right now ... are our national security and our economic prosperity, which is why we must continue to have a strong and effective International Affairs Budget," U.S. Global Leadership Coalition Communications Director Richard Parker writes in a FoxNews.com opinion piece.

5 Jan 2011

AHF to supply $1 million in free AIDS drugs to Florida's disenrolled and wait listed HIV/AIDS patients

As the State of Florida grapples with a budget shortfall that has crippled its AIDS Drug Assistance Program (ADAP) and forced the state to potentially disenroll 350 Florida patients already on ADAP as well as place nearly 2,400 low-income Floridians on waiting lists to access lifesaving medications, AIDS Healthcare Foundation (AHF) has proposed an innovative plan to help state health officials and displaced HIV/AIDS patients bridge the transition to private patient assistance programs run by the major pharmaceutical companies.

4 Jan 2011

New ATS guidelines for treating fungal infection in adult pulmonary and critical care patients

The American Thoracic Society has released a new official clinical policy statement on the treatment of fungal infections in adult pulmonary and critical care patients.

4 Jan 2011

FDA approves 200 mg formulation of INTELENCE for HIV-1

The U.S. Food and Drug Administration (FDA) approved a label update to include a 200 mg formulation of INTELENCE® (etravirine), a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated for the treatment of human immunodeficiency virus (HIV-1) in treatment-experienced adults with resistance to an NNRTI and other antiretroviral (ARV) agents.

3 Jan 2011

HIV 1 News and Research

RTS,S offers 46 percent protection against malaria for at least 15 months after vaccination, Study finds

Clinical studies by expert HIV clinicians suggest that HIV-TRePS may have clinical and economic benefits

Opinions: U.S. HIV funding; Global fund accountability; World food supply

New evidence about broadly-reactive neutralizing antibodies that block HIV infection

Medical aid workers should take pre-travel precautions to prevent disease transmission

Sangamo completes enrollment in SB-509-901 Phase 2b clinical trial in diabetic neuropathy

Positive preclinical results from Inovio's novel DNA vaccine targeting HIV Clade C virus

Male circumcision helps reduce rates of HPV transmission to women, study finds

New lab-on-a-chip technology detects protein in blood less than 30 minutes

IDSA releases MRSA treatment guidelines

Opinions: Global health top foreign policy issue; Global food security; Opiate-substitution programs in Eastern Europe; Feed the future; Foreign aid lessons

Profectus BioSciences commences GENEVAX IL-12 phase 1 study for HIV

Indian drugmaker seeks to make, sell generic version of Pfizer's HIV drug

OpEds: Sebelius, Fla. Attorney General, USA Today, Wash Post opine about repeal strategies

UC professor receives Fulbright Scholar Award to explore health education efforts in China

Indian government rejects Abbott's patent application for second-line ARV

Opinions: U.S. International Affairs Budget; Health impacts of climate change; Role of U.N.; Drug development, free trade

AHF to supply $1 million in free AIDS drugs to Florida's disenrolled and wait listed HIV/AIDS patients

New ATS guidelines for treating fungal infection in adult pulmonary and critical care patients

FDA approves 200 mg formulation of INTELENCE for HIV-1

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News